Success for oncologists under alternative payment models is heavily driven by their ability to control antineoplastic drug spending and hospital use, researchers concluded after conducting a retrospective cohort study involving nearly 5,000 individuals. Participants were ≥65 years of age with primary fee-for-service Medicare insurance. They received antineoplastic therapy at 12 southeastern cancer centers between 2012 and 2014. Investigators looked at spending prechemotherapy and during Oncology Care Model episodes of care that led to antineoplastic therapy. They specifically assessed spending/episode, as well as spending by type of service. Among the results:
- Average spending in the first, second, and third episodes of care was ~$34,000, ~$24,000, and ~$19,000, respectively.
- Antineoplastic drugs accounted for 27%, 32%, and 36% of spending, respectively.
- 10 medications—used by 31% of patients—represented 61% of the drug spend in the first episode.
- Inpatient spending accounted for 17% to 20% of total spending.
Rocque G, Williams C, Kenzik K, et al. Where are the opportunities for reducing health care spending within alternative payment models? [Published online ahead of print October 5, 2017]. J Oncol Pract. doi:10.1200/JOP.2017.024935.
This Week's Must Reads
Durvalumab Post-Chemoradiotherapy in NSCLC Assessed, N Engl J Med; ePub 2017 Sep 8; Antonia, et al
Cochrane on Detecting CRC in Patients with IBD, Cochrane; 2017 Sep 18; Bye, Nguyen, Parker, et al
Lymph Node Removal During Endometrial Ca Surgery, Cochrane; 2017 Oct 2; Frost, Webster, et al
Cochrane on Reducing Neoplasia in Molar Pregnancy, Cochrane; 2017 Sep 11; Wang, Fu, Hu, et al
Cochrane on Reconstructing the Pancreatic Stump, Cochrane; 2017 Sep 12; Cheng, Briarava, et al
Must Reads in Practice Management
ACA Dependent Coverage Expansion Impact Assessed, Cancer; ePub 2017 Sep 22; Alvarez, Keegan, et al
Reducing Spending Under Alternative Pay Models, J Oncol Pract; ePub 2017 Oct 5; Rocque, et al
Infusion Therapy Patterns by Treatment Site Studied, J Med Econ; ePub 2017 Sep 25; Hopson, et al
This Impacts CRC Screening Rates in Some Minorities, Cancer; ePub 2017 Oct 4; Hong, Tauscher, et al
HCT Centers: Models for Specialty Medical Homes, Biol Blood Marrow Transplant; ePub 2017 Sep 26; Gajewski, et al